Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
JTO Clinical and Research Reports
|
September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping
Marissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease
Wade T Iams, Prasad R Kopparapu, Yingjun Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2025
A phase Ib study of sapacitabine and olaparib in patients with BRCA1/2-mutated metastatic breast cancer
Filipa Lynce, Noah Graham, Bose S Kochupurakkal, et al.
Cell Cycle (Georgetown, Tex.)
|
October 14, 2009
microRNAs regulate human embryonic stem cell division
Junlin Qi, Jenn-Yah Yu, Halyna R Shcherbata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Leora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Nature
|
November 11, 2021
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao, Yonina R Murciano-Goroff, Jenny Y Xue, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
JTO Clinical and Research Reports
|
September 30, 2021
SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping
Marissa N Lawrence, Rubii M Tamen, Pablo Martinez, et al.
JTO Clinical and Research Reports
|
September 30, 2021
Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease
Wade T Iams, Prasad R Kopparapu, Yingjun Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 3, 2025
A phase Ib study of sapacitabine and olaparib in patients with BRCA1/2-mutated metastatic breast cancer
Filipa Lynce, Noah Graham, Bose S Kochupurakkal, et al.
Cell Cycle (Georgetown, Tex.)
|
October 14, 2009
microRNAs regulate human embryonic stem cell division
Junlin Qi, Jenn-Yah Yu, Halyna R Shcherbata, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 26, 2019
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Leora Horn, Jennifer G Whisenant, Heather Wakelee, et al.
Nature
|
November 11, 2021
Diverse alterations associated with resistance to KRAS(G12C) inhibition
Yulei Zhao, Yonina R Murciano-Goroff, Jenny Y Xue, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 9, 2021
Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66-73]
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 26, 2021
Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
Sebastian Mondaca, Emily S Lebow, Azadeh Namakydoust, et al.
Journal of the National Cancer Institute
|
November 30, 2018
A Prospective Study of Circulating Tumor DNA to Guide Matched Targeted Therapy in Lung Cancers
Joshua K Sabari, Michael Offin, Dennis Stephens, et al.
The New England Journal of Medicine
|
June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in Cancer
Mark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Page
of 4